Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Peripheral neuropathy
by Highest Patent Value in the China in 2022

The Peripheral neuropathy top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Peripheral neuropathy Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A disease affecting peripheral nerves.
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 340,000
2
Glucophage,Metformin,Drug,
...[+2]
Avg patent value: 130,000
3
Health care,Medicine,Drug,
...[+2]
Avg patent value: 120,000
4
Avg patent value: 120,000
5
Avg patent value: 101,500
6
Avg patent value: 98,000
7
Avg patent value: 91,000
8
Avg patent value: 80,000
9
Avg patent value: 80,000
10
ARURA TIBETAN MEDICINE CO.LTD.
Avg patent value: 69,000
11
Avg patent value: 63,000
12
Avg patent value: 62,000
13
Avg patent value: 50,000
14
Avg patent value: 47,000
15
Avg patent value: 25,000
16
Medicine,Cultural industry,Corporate group,
...[+1]
Avg patent value: 3,500
17
Avg patent value: 3,500
18
Avg patent value: 3,500
19
Avg patent value: 3,450
20
Medicine,Health care,Topical analgesics,
...[+2]
Avg patent value: 3,400
Page generation time: Jun 22 2025